The Australian researchers developed a novel mRNA-based technology capable of reaching the white blood cells where HIV lies ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

So despite the success of HIV drugs and PrEP, precarious health-care systems and high drug costs mean we can't rely on them to bring an end to the ongoing global HIV pandemic. Tha ...

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

Out of the ashes of this tragedy arose one of the miracles of modern medicine. Thanks to the work of patient advocates, patients themselves and intrepid researchers, the landscape of HIV and AIDS has ...

Gilead's lenacapavir approval by the US Food and Drug Administration (FDA) marks a milestone in HIV prevention, but experts warn over its expense. Sophie Cousins reports.